查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922540

日本神经调控市场报告：按技术、生物材料、应用和地区划分（2026-2034年）

Japan Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本神经调控市场规模达3.938亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到11.034亿美元，2026年至2034年的复合年增长率（CAGR）为12.13%。推动日本市场成长的关键因素包括：人口老化加剧、近期技术进步、医疗费用支出增加、人们对神经调控益处的认识不断提高、主要市场参与者的强大影响力以及优惠的报销政策。

神经调控是一种透过向神经系统特定区域传递药物或电刺激来调节神经活动的疗法。神经调控有多种类型，包括脊髓刺激、深部脑部刺激、荐椎神经刺激和周边神经刺激。神经调控设备由多个组件构成，包括脉衝产生器、电极和手持式程式设计设备。它们具有许多优势，例如微创性、可自订的治疗设定和即时回馈机制。神经调控广泛用于治疗慢性疼痛、癫痫、运动障碍、精神疾病、偏头痛和胃肠道疾病。与全身给药相比，神经调控具有标靶治疗、副作用更少、可逆性以及远端患者监护等优势。此外，它还具有许多益处，例如提高患者依从性、改善生活品质、长期成本效益以及能够即时调整治疗设定。

日本神经调控市场趋势：

日本人口老化加剧，导致神经系统疾病和慢性疾病发生率上升，从而推动了市场成长。此外，无线神经调控技术的出现等近期技术进步，拓展了神经调控的应用范围，进一步促进了市场成长。医疗费用支出的增加和神经系统研究日益受到重视，也推动了市场成长，为市场扩张创造了有利环境。此外，人们对神经调控益处的认识不断提高，加快了其应用普及速度，进一步推动了市场成长。主要市场参与者在日本的强大影响力以及频繁的新产品发布也刺激了市场成长。此外，政府医疗保健系统推出的针对神经调控手术的优惠报销政策也推动了市场成长。临床试验不断证实神经调控技术的有效性，进一步增强了人们对技术的信心，对市场成长产生了正面影响。同时，对微创手术的广泛需求推动了神经调控技术的应用，支持了市场成长。因此，神经调控领域专业医疗人员数量的增加也推动了市场成长。此外，人工智慧（AI）在即时调整和监测方面的应用对市场成长产生了积极影响。同时，患者对神经调控的依从性和满意度的提高，也带动了患者转诊量的增加，进而推动了市场成长。此外，主要企业之间不断增加的策略合作和收购，进一步拓展了研究并利用了共用的专业知识，从而增强了市场成长。此外，公共和私人部门对研发活动的投资不断增加，也推动了市场成长。

本报告解答的关键问题：

  • 日本神经调控市场目前发展状况如何？您认为未来几年它将如何发展？
  • 新冠疫情对日本神经调控市场产生了哪些影响？
  • 日本神经调控市场依技术分類的构成比是怎样的？
  • 日本生物材料神经调控市场的市场组成是怎样的？
  • 日本神经调控市场按应用领域是如何细分的？
  • 日本神经调控市场价值链的不同阶段有哪些？
  • 日本神经调控市场的主要驱动因素和挑战是什么？
  • 日本神经调控市场的结构是怎么样的呢？主要参与者有哪些？
  • 日本神经调控市场竞争有多激烈？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章 日本神经调控市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本神经调控市场概览

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本神经调控市场－依技术细分

  • 内部神经调节
  • 外部神经调控

第七章 日本神经调控市场－依生物材料细分

  • 金属生物材料
  • 高分子生物材料
  • 陶瓷生物材料

第八章 日本神经调控市场－依应用领域细分

  • 帕金森氏症
  • 癫痫
  • 忧郁症
  • 肌张力不全症
  • 疼痛管理
  • 其他的

第九章：日本神经调控市场－依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章 日本神经调控市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章 日本神经调控市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A19378

Japan neuromodulation market size reached USD 393.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,103.4 Million by 2034, exhibiting a growth rate (CAGR) of 12.13% during 2026-2034. The rising geriatric population in Japan, recent technological advancements, increasing healthcare expenditure, heightened awareness about the benefits of neuromodulation, strong presence of key market players, and introduction of favorable reimbursement policies represent some of the key factors driving the market.

Neuromodulation refers to a technology involving the modification of nerve activity by delivering pharmaceutical or electrical agents to targeted areas of the nervous system. It encompasses a wide range of types, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and peripheral nerve stimulation. Neuromodulation is comprised of several components, such as a pulse generator, electrodes, and a handheld device for programming. It offers multiple features, including minimally invasive procedures, customizable treatment settings, and real-time feedback mechanisms. Neuromodulation is widely used for treating chronic pain, epilepsy, movement disorders, psychiatric conditions, migraines, and gastrointestinal issues. It offers targeted therapy, reduced side effects as compared to systemic drug administration, reversibility, and the potential for remote patient monitoring. Additionally, neuromodulation provides several advantages, such as enhanced patient compliance, better quality of life, cost-effectiveness in the long run, and the opportunity for real-time adjustments to treatment settings.

Japan Neuromodulation Market Trends:

The rising geriatric population in Japan, contributing to the escalating incidences of neurological and chronic disorders, is propelling the market growth. Additionally, recent technological advancements, such as the advent of wireless neuromodulation, that are expanding the technique's applications are driving the market growth. Besides this, the increasing healthcare spending and the prioritization of neurological research, fostering a conducive environment for market expansion, is acting as another growth-inducing factor. Furthermore, the heightened awareness about the benefits of neuromodulation, which is facilitating faster adoption rates, is catalyzing the market growth. In addition to this, the strong presence of key market players and frequent product launches in Japan is stimulating the market growth. Apart from this, the introduction of favorable reimbursement policies by the government healthcare system for neuromodulation procedures is bolstering the market growth. Moreover, the growing evidence of the efficacy of neuromodulation through clinical trials, lending further credence to the technology, is positively influencing the market growth. Along with this, the widespread demand for minimally invasive procedures, boosting neuromodulation applications, is supporting the market growth. In line with this, the escalating number of skilled healthcare professionals in the field of neuromodulation is driving the market growth. Furthermore, the integration of artificial intelligence (AI) for real-time adjustments and monitoring is creating a positive outlook for the market growth. In addition, the rising patient compliance and satisfaction rates with neuromodulation, encouraging more referrals, is accelerating the market growth. Besides this, the increasing strategic collaborations and acquisitions among key players to expand further research and leverage shared expertise are strengthening the market growth. Additionally, the growing public and private investment in research and development (R&D) activities is fueling the market growth.

Japan Neuromodulation Market Segmentation:

Technology Insights:

  • Internal Neuromodulation
    • Spinal Cord Stimulation (SCS)
    • Deep Brain Stimulation (DBS)
    • Vagus Nerve Stimulation (VNS)
    • Sacral Nerve Stimulation (SNS)
    • Gastric Electrical Stimulation (GES)
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transcranial Magnetic Stimulation (TMS)
    • Others

Biomaterial Insights:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

Application Insights:

  • Parkinson's Disease
  • Epilepsy
  • Depression
  • Dystonia
  • Pain Management
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neuromodulation market?
  • What is the breakup of the Japan neuromodulation market on the basis of technology?
  • What is the breakup of the Japan neuromodulation market on the basis of biomaterial?
  • What is the breakup of the Japan neuromodulation market on the basis of application?
  • What are the various stages in the value chain of the Japan neuromodulation market?
  • What are the key driving factors and challenges in the Japan neuromodulation?
  • What is the structure of the Japan neuromodulation market and who are the key players?
  • What is the degree of competition in the Japan neuromodulation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neuromodulation Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neuromodulation Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Neuromodulation Market - Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Spinal Cord Stimulation (SCS)
      • 6.1.3.2 Deep Brain Stimulation (DBS)
      • 6.1.3.3 Vagus Nerve Stimulation (VNS)
      • 6.1.3.4 Sacral Nerve Stimulation (SNS)
      • 6.1.3.5 Gastric Electrical Stimulation (GES)
    • 6.1.4 Market Forecast (2026-2034)
  • 6.2 External Neuromodulation
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.3.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.3.3 Others
    • 6.2.4 Market Forecast (2026-2034)

7 Japan Neuromodulation Market - Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)

8 Japan Neuromodulation Market - Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Epilepsy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Depression
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Dystonia
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2020-2025)
    • 8.6.2 Market Forecast (2026-2034)

9 Japan Neuromodulation Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Technology
    • 9.1.4 Market Breakup by Biomaterial
    • 9.1.5 Market Breakup by Application
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Technology
    • 9.2.4 Market Breakup by Biomaterial
    • 9.2.5 Market Breakup by Application
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Technology
    • 9.3.4 Market Breakup by Biomaterial
    • 9.3.5 Market Breakup by Application
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Technology
    • 9.4.4 Market Breakup by Biomaterial
    • 9.4.5 Market Breakup by Application
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Technology
    • 9.5.4 Market Breakup by Biomaterial
    • 9.5.5 Market Breakup by Application
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Technology
    • 9.6.4 Market Breakup by Biomaterial
    • 9.6.5 Market Breakup by Application
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Technology
    • 9.7.4 Market Breakup by Biomaterial
    • 9.7.5 Market Breakup by Application
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Technology
    • 9.8.4 Market Breakup by Biomaterial
    • 9.8.5 Market Breakup by Application
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Neuromodulation Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Services Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Services Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Services Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Services Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Services Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Neuromodulation Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix